- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 재발성 NSCLC in China
총 1026 건
-
Convalife (Shanghai) Co., Ltd.아직 모집하지 않음
-
Wuhan Union Hospital, China모병
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.알려지지 않은
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...모병
-
Pfizer완전한ALK 양성 비소세포폐암(NSCLC) 및 ROS1 양성 NSCLC미국, 캐나다, 호주, 대만, 싱가포르, 일본, 대한민국, 스페인, 벨기에, 스위스, 프랑스, 독일, 홍콩, 이탈리아
-
Beijng Immunoah Pharma Tech Co., Ltd.모병
-
Henan Cancer HospitalCttq알려지지 않은
-
Nanfang Hospital of Southern Medical University알려지지 않은
-
Peking University Cancer Hospital & InstituteGeneplus-Beijing Co. Ltd.모병
-
Shanghai Chest HospitalShanghai Junshi Bioscience Co., Ltd.모병
-
Betta Pharmaceuticals Co., Ltd.알려지지 않은
-
Shanghai Chest Hospital알려지지 않은
-
Tianjin Medical University Cancer Institute and...모병
-
The Affiliated Hospital of Qingdao University완전한
-
First Affiliated Hospital Xi'an Jiaotong UniversityTang-Du Hospital; Yan'an University Affiliated Hospital알려지지 않은
-
First People's Hospital of HangzhouHangzhou Cancer Hospital모병
-
Shanghai Chest HospitalMerck Sharp & Dohme LLC모병
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGene모병
-
Beijing Haidian Hospital307 Hospital of PLA; Peking University People's Hospital; 309th Hospital of Chinese People...모병
-
Xinqiao Hospital of Chongqing완전한
-
Affiliated Hospital of North Sichuan Medical CollegeJiangsu HengRui Medicine Co., Ltd.알려지지 않은
-
AstraZeneca완전한비NSCLC 환자의 EGFR 돌연변이 상태대한민국, 러시아 연방, 말레이시아, 중국, 호주, 대만, 태국, 인도네시아, 싱가포르
-
Guangdong Association of Clinical Trials알려지지 않은
-
Jiangsu Cancer Institute & Hospital아직 모집하지 않음
-
Pierre Fabre Medicament완전한흑색종 | BRAF V600E 절제 불가능 또는 전이성 흑색종 | BRAF V600E 전이성 NSCLC중국
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbH모병
-
Allist Pharmaceuticals, Inc.알려지지 않은
-
Beijing Mabworks Biotech Co., Ltd.모병
-
Jiangsu Province Nanjing Brain Hospital모병
-
Innovent Biologics (Suzhou) Co. Ltd.WuXi CDS Clinical Research (Shanghai) Co.Ltd.완전한